Aspen Group, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details)							1 Months Ended			3 Months Ended			6 Months Ended
Stockholders' Equity (Details)	Aug. 20, 2019 investor shares	Aug. 17, 2019 shares	Aug. 01, 2019 USD ($) subsidiary $ / shares shares	Jun. 18, 2019 shares	May 13, 2019 $ / shares shares	Dec. 24, 2018 shares	Nov. 30, 2019 shares	Dec. 24, 2018 USD ($) shares	Sep. 30, 2018 USD ($) $ / shares shares	Oct. 31, 2019 USD ($) shares	Jul. 31, 2019 USD ($) shares	Oct. 31, 2018 USD ($) shares	Oct. 31, 2019 USD ($) shares	Oct. 31, 2018 USD ($) shares	Dec. 30, 2019 shares	Jun. 28, 2019 shares	Jun. 07, 2019 shares	Jun. 03, 2019 shares	Apr. 30, 2019 shares	Dec. 13, 2018 shares	Mar. 13, 2012 shares
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)										1,000,000			1,000,000						1,000,000
Preferred stock issued (in shares)										0			0						0
Preferred stock outstanding (in shares)										0			0						0
Common stock, shares authorized (in shares)										40,000,000			40,000,000						40,000,000
Common stock issued for stock options exercised for cash \| $										$ 192,522	$ 45,190	$ 52,285	$ 237,713	$ 60,102
Restricted stock issued, fair value \| $													$ 0
Weighted average recognition period													2 years
Common stock issued (in shares)										19,142,316			19,142,316						18,665,551
Number of investors electing cashless exercises \| investor	2
Compensation expense \| $										$ 492,130			$ 990,547
Unrecognized compensation costs \| $										$ 1,300,000			$ 1,300,000
Investor
Stockholders Equity [Line Items]
Restricted shares granted (in shares)													25,000
Restricted shares granted, value \| $													$ 122,250
Subsequent Event
Stockholders Equity [Line Items]
Restricted stock issued (in shares)							26,050
Equity Incentive Plan
Stockholders Equity [Line Items]
Number of shares granted (in shares)										180,434			180,434
Number of shares authorized (in shares)																				500,000	3,500,000
Common stock, shares remaining for future issuance (in shares)										13,852			13,852
Equity Incentive Plan \| Subsequent Event
Stockholders Equity [Line Items]
Number of shares authorized (in shares)															500,000
Equity Incentive Plan \| Scenario, Plan \| Subsequent Event
Stockholders Equity [Line Items]
Number of shares authorized (in shares)															1,100,000
Common Stock
Stockholders Equity [Line Items]
Common stock issued for cashless stock options exercised (in shares)										80,313	101,894	25,534	182,207	30,764
Common stock issued for cashless warrant exercise (in shares)										57,526	19,403		76,929
Cashless exercise of warrants (in shares)										121,070	43,860
Common stock issued for stock options exercised for cash (in shares)										90,950	21,876	24,118	112,826	26,807
Common stock issued for stock options exercised for cash \| $										$ 90		$ 24	$ 113	$ 26
Restricted stock issued (in shares)													104,803
Restricted stock issued, fair value \| $													$ 104
Common Stock \| Minimum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																40,000,000
Common Stock \| Maximum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																250,000,000
Preferred Stock \| Minimum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																1,000,000
Preferred Stock \| Maximum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																10,000,000
Warrant
Stockholders Equity [Line Items]
Unvested shares of restricted common stock outstanding (in shares)										69,672			69,672
Total unrecognized compensation expense \| $										$ 249,000			$ 249,000
Director
Stockholders Equity [Line Items]
Restricted stock issued (in shares)											30,131
Restricted stock issued, fair value \| $											$ 122,332
Former Director
Stockholders Equity [Line Items]
Common stock issued (in shares)																		9,806
Former Director \| Warrant
Stockholders Equity [Line Items]
Common stock issued (in shares)																		21,930
Chief Executive Officer
Stockholders Equity [Line Items]
Common stock issued (in shares)																	9,597
Investor 1
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)	8,970
Investor 1 \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)	18,818
Investor 2
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)	42,285
Investor 2 \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)	88,710
Investor
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)		6,271
Investor \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)		13,542
Executive Officer
Stockholders Equity [Line Items]
Stock based compensation expense \| $										$ 101,063
Restricted Stock
Stockholders Equity [Line Items]
Restricted stock vesting period						36 months
Number of shares granted (in shares)						24,672		24,672
Restricted Stock \| Investor
Stockholders Equity [Line Items]
Restricted shares vested (in shares)										5,000			5,000
Restricted Stock \| Andrew Kaplan Current Director
Stockholders Equity [Line Items]
Granted (in shares)				5,131
Options granted (in shares)				5,131
Restricted Stock \| Two former directors
Stockholders Equity [Line Items]
Granted (in shares)				25,000
Options granted (in shares)				25,000
Restricted Stock \| Director
Stockholders Equity [Line Items]
Restricted shares granted, value \| $								$ 126,320
Restricted Stock \| Chief Financial Officer
Stockholders Equity [Line Items]
Total unrecognized compensation expense \| $									$ 180,000
Restricted shares granted (in shares)									25,000
Restricted stock vesting period									36 months
Restricted stock price on date of grant (in dollars per share) \| $ / shares									$ 7.15
Weighted average recognition period									36 months
Non-qualified stock options to certain former directors
Stockholders Equity [Line Items]
Granted (in shares)					30,000
Options granted (in shares)					30,000
Terms of share-based payment award					five years
Share-based payment award exercise price (in dollars per share) \| $ / shares					$ 4.12
Share-based Payment Arrangement, Option
Stockholders Equity [Line Items]
Granted (in shares)			59,000
Options granted (in shares)			59,000
Options granted, number of employees \| subsidiary			26
Fair value of stock options \| $			$ 83,000
Recognition period of stock options (in months)			36 months
Exercise price of options (in dollars per share) \| $ / shares			$ 3.99